Progress in cancer therapy over the past decades improved long-term survival but increased
cancer therapy-related cardiotoxicity. Many novel treatment options have been implemented …

In cancer patients, pulmonary embolism (PE) is the second leading cause of death after the
cancer itself, most likely because of difficulties in diagnosing the disease due to its …

The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

Essentials We performed a pooled analysis of 926 patients with cancer‐associated
incidental pulmonary embolism (IPE). Vitamin K antagonists (VKA) are associated with a …

Background Failure to test for pulmonary embolism (PE) can be a lethal mistake, but PE and
produces symptoms similar to many other diseases. Overtesting for PE has negative …

Clinically unsuspected pulmonary embolism (UPE) is frequently diagnosed in cancer
patients undergoing routine computed tomography scans for staging purposes or treatment …

Objectives The objective of this study is to describe the clinical use and safety profile of low-
dose ketamine (LDK)(0.1-0.3 mg/kg) for pain management in the emergency department …

Venous thromboembolism is a common complication in cancer patients, and
thromboembolism is the second most common cause of death after cancer progression. A …

Background Pulmonary embolism (PE) is a common cause of morbidity and mortality in
oncologic patients. Furthermore, PE is an unsuspected finding in many cases. Purpose To …

Objectives The purpose of this study was to evaluate the incremental value of artificial
intelligence (AI) compared to the diagnostic accuracy of radiologists alone in detecting …